<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_pReQV3Y">Cost-Effectiveness of Digital Health Interventions for Asthma or COPD: Systematic Review</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Marta</forename><surname>Alexandra</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Martins</forename><surname>Ferreira</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Faculty of Health Sciences , University of Beira Interior , Covilha , Portugal |</note>
								<orgName type="department">Faculty of Health Sciences</orgName>
								<orgName type="institution">University of Beira Interior</orgName>
								<address>
									<settlement>Covilha</settlement>
									<country>Portugal |</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Adalberto</forename><surname>Fernandes Dos Santos</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Faculty of Medicine , Agostinho Neto University , Luanda , Angola |</note>
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">Agostinho Neto University</orgName>
								<address>
									<settlement>Luanda</settlement>
									<country>Angola |</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> UBIAir-Clinical &amp; Experimental Lung Centre , UBIMedical , University of Beira Interior , Covilha , Portugal |</note>
								<orgName type="department">UBIAir-Clinical &amp; Experimental Lung Centre</orgName>
								<orgName type="institution" key="instit1">UBIMedical</orgName>
								<orgName type="institution" key="instit2">University of Beira Interior</orgName>
								<address>
									<settlement>Covilha</settlement>
									<country>Portugal |</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> CICS-UBI-Health Sciences Research Centre , University of Beira Interior , Covilha , Portugal |</note>
								<orgName type="department">CICS-UBI-Health Sciences Research Centre</orgName>
								<orgName type="institution">University of Beira Interior</orgName>
								<address>
									<settlement>Covilha</settlement>
									<country>Portugal |</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Bernardo</forename><surname>Sousa-Pinto</surname></persName>
							<email>bernardo@med.up.pt</email>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> MEDCIDS-Department of Community Medicine , Information and Health Decision Sciences , Faculty of Medicine , University of Porto , Porto , Portugal</note>
								<orgName type="department" key="dep1">MEDCIDS-Department of Community Medicine</orgName>
								<orgName type="department" key="dep2">Information and Health Decision Sciences</orgName>
								<orgName type="department" key="dep3">Faculty of Medicine</orgName>
								<orgName type="institution">University of Porto</orgName>
								<address>
									<settlement>Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>6</label> Centre for Health Technology and Services Research , Health Research Network ( CINTESIS@RISE) , Faculty of Medicine , University of Porto , Porto , Portugal</note>
								<orgName type="department" key="dep1">CINTESIS@RISE)</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="laboratory" key="lab1">Centre for Health Technology and Services Research</orgName>
								<orgName type="laboratory" key="lab2">Health Research Network (</orgName>
								<orgName type="institution">University of Porto</orgName>
								<address>
									<settlement>Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Luís Taborda-Barata</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Faculty of Health Sciences , University of Beira Interior , Covilha , Portugal |</note>
								<orgName type="department">Faculty of Health Sciences</orgName>
								<orgName type="institution">University of Beira Interior</orgName>
								<address>
									<settlement>Covilha</settlement>
									<country>Portugal |</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> UBIAir-Clinical &amp; Experimental Lung Centre , UBIMedical , University of Beira Interior , Covilha , Portugal |</note>
								<orgName type="department">UBIAir-Clinical &amp; Experimental Lung Centre</orgName>
								<orgName type="institution" key="instit1">UBIMedical</orgName>
								<orgName type="institution" key="instit2">University of Beira Interior</orgName>
								<address>
									<settlement>Covilha</settlement>
									<country>Portugal |</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> CICS-UBI-Health Sciences Research Centre , University of Beira Interior , Covilha , Portugal |</note>
								<orgName type="department">CICS-UBI-Health Sciences Research Centre</orgName>
								<orgName type="institution">University of Beira Interior</orgName>
								<address>
									<settlement>Covilha</settlement>
									<country>Portugal |</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bernardo</forename><surname>Sousa</surname></persName>
						</author>
						<title level="a" type="main" xml:id="_WauukSb">Cost-Effectiveness of Digital Health Interventions for Asthma or COPD: Systematic Review</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">FF8A8FB4FB7E78020D4042B79E61CFFB</idno>
					<idno type="DOI">10.1111/cea.14547</idno>
					<note type="submission">Received: 15 April 2024 | Revised: 4 July 2024 | Accepted: 7 July 2024</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T07:06+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_zmQ79Hm">asthma</term>
					<term xml:id="_skmKfRu">COPD</term>
					<term xml:id="_chvukVC">cost-effectiveness</term>
					<term xml:id="_QxFdwKR">costs</term>
					<term xml:id="_jH363Wu">cost-utility</term>
					<term xml:id="_sJvr53X">telemedicine</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_aX5zJvn"><p xml:id="_SmpFasx"><s xml:id="_XDcRu5W">Objective: Digital interventions such as remote monitoring of symptoms and physiological measurements have the potential to reduce the economic burden of asthma and chronic obstructive pulmonary disease (COPD) but their cost-effectiveness remains unclear.</s><s xml:id="_vgZuT5C">This systematic review of randomised controlled trials (RCT) aims to assess whether digital health interventions can be cost-effective in these patients.</s><s xml:id="_x4NPquQ">Design: Systematic review of RCTs.</s><s xml:id="_VFPp5kp">Study quality was assessed using RoB2 tool.</s><s xml:id="_PknSpQb">Data Sources: Systematic search in three databases: PubMed, Scopus and Web of Science.</s><s xml:id="_hpVxnyp">Eligibility Criteria: Studies were eligible if they were RCTs with health economic evaluations assessing participants with asthma and/or COPD and comparing a digital health intervention to standard of care.</s><s xml:id="_nSAbWDy">Results: We included 35 RCTs, of which 21 were related to COPD, 13 to asthma and one to both diseases.</s><s xml:id="_7yHZggN">Overall, studies assessed four categories of digital health interventions: (i) Electronic patient diaries (n = 4), (ii) real-time monitoring (n = 19), (iii) teleconsultations (n = 6) and (iv) others (n = 6).</s><s xml:id="_QuRkf4m">Eleven studies performed a full economic evaluation analysis, while 24 studies performed a partial economic analysis.</s><s xml:id="_gBcY5q8">Most studies involving real-time monitoring or teleconsultations presented economic results in favour of digital health interventions (indicating them to be cost-effective or less expensive than the standard of care).</s><s xml:id="_2AWj7BR">Mixed results were obtained for electronic patient diaries.</s><s xml:id="_ZpwTQTu">In the studies that conducted a full economic analysis, the incremental cost-effectiveness ratio (ICER) ranged from 3530,93€/QALY and 286,369,28€/QALY.</s><s xml:id="_vdzuXgM">In the studies that conducted a partial economic analysis, the cost differences between the intervention group and the control group ranged from 0,12€ and 85,217,86€.</s><s xml:id="_7pknYKp">Half studies with low risk of bias concluded that the intervention was economically favourable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xRkkhhN">Conclusion:</head><p xml:id="_GD8Fjdq"><s xml:id="_uDMPtYe">Although costs varied based on intervention type, follow-up period and country, most studies report digital health interventions to be affordable or associated with decreased costs.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="595.276" lry="782.362"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1" xml:id="_p5XnUPU">| Introduction</head><p xml:id="_zhsHyve"><s xml:id="_q2murG7">Asthma and chronic obstructive pulmonary disease (COPD) are common chronic respiratory conditions that substantially impact patients' quality of life, being associated with high rates of disability, morbidity and mortality <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_DZq6yhT">In 2019, asthma was responsible for 21.6 million disability-adjusted life years (DALYs) (20.8% of total DALYs from chronic respiratory disease <ref type="bibr" target="#b1">[2]</ref>) and for 455,000 deaths worldwide <ref type="bibr" target="#b2">[3]</ref>.</s><s xml:id="_Jfy6vgC">Similarly, COPD accounted for 3.2 million deaths, being the third leading cause of death worldwide <ref type="bibr" target="#b3">[4]</ref>.</s><s xml:id="_TvFsm3e">These two diseases also impose a substantial economic burden on individuals and societies.</s><s xml:id="_uqueDaW">In fact, according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), respiratory diseases account for 6% of the total annual healthcare budget of the European Union in direct costs, with COPD alone contributing to 56% (€38.6 billion) of the overall expenses <ref type="bibr" target="#b4">[5]</ref>.</s><s xml:id="_xtaGt7p">Identically, Nunes, Pereira, and Morais-Almeida <ref type="bibr" target="#b5">[6]</ref> estimated that the disease burden of asthma (including indirect costs) accounted for over €19 billion in Europe.</s></p><p xml:id="_6eaJa6h"><s xml:id="_J7pyWZV">A significant proportion of the economic burden associated with these conditions arises from exacerbations, as they may result in emergency department visits and hospitalisations, increased use of medication, and absence from school or work.</s><s xml:id="_2RZpnB9">Therefore, preventing exacerbations stands out as a crucial objective for both asthma and COPD.</s><s xml:id="_dhBTfXV">In order to achieve this goal, regular patient follow-up may be particularly needed.</s><s xml:id="_nDM7vem">Symptoms and objective measures of airflow obstruction should be monitored frequently, to identify potential complications and allow timely adjustments in the treatment plan to prevent them <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8]</ref>.</s><s xml:id="_MkUmxKc">In this context, telemedicine may play a particularly relevant role.</s><s xml:id="_Ad68Jka">It is defined as 'the provision of healthcare services at a distance with communication conducted between healthcare providers seeking clinical guidance and support from other healthcare providers (provider-to-provider telemedicine); or conducted between remote healthcare users seeking health services and healthcare providers (client-to-provider telemedicine)' <ref type="bibr" target="#b8">[9]</ref>.</s><s xml:id="_hu4WMGN">Telemedicine interventions can enable healthcare delivery through many ways, such as video-consultations, phone calls, real-time monitoring with home devices as spirometers or pulmonary telerehabilitation.</s><s xml:id="_45PMKQg">These services allow for continuous monitoring of patients, which can alert healthcare professionals to changes in symptoms and/or physiological parameters and facilitate early intervention before the occurrence of a severe exacerbation.</s><s xml:id="_Ex3tgvA">Telemedicine approaches might even provide more accurate information on the patients' disease control compared with face-to-face consultations <ref type="bibr" target="#b9">[10]</ref> and to remind patients to take their medications or vaccines.</s><s xml:id="_yjVxXPu">In addition, wearable or implementable digital devices can collect data on biomarkers relevant for monitoring patients with respiratory disease (such as serum immunoglobulin E, sputum and blood eosinophils, and the fraction of nitric oxide in exhaled air), whose assessment, combined with other clinical and physiological parameters, has the potential to prevent exacerbations and improve the precision therapeutic approach to asthma <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref>.</s></p><p xml:id="_hq6HQWX"><s xml:id="_DKrXxwK">Although telemedicine has already demonstrated its potential to reduce healthcare utilisation and improve quality of life in patients with these two diseases <ref type="bibr" target="#b13">[14]</ref>, having the potential to be associated with a reduction in costs, it is still unclear if it is costeffective in managing asthma or COPD.</s><s xml:id="_hu6Se8E">Therefore, this systematic review of randomised controlled trials (RCT) aims to assess whether telemedicine interventions can be cost-effective in patients with asthma or COPD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2" xml:id="_JVRjNqf">| Methods</head><p xml:id="_U9JF23u"><s xml:id="_UbdFqvx">The protocol for this systematic review is published on PROSPERO (International Prospective Register of Systematic Reviews.</s><s xml:id="_JdwHwJv">ID: CRD42023439195).</s><s xml:id="_XTPEQXF">A copy of this protocol is available in File S1.</s><s xml:id="_fqtZpmA">This systematic review was conducted in accordance with PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and represented in Figure <ref type="figure">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1" xml:id="_XShuZBH">| Eligibility Criteria</head><p xml:id="_NnQgdJE"><s xml:id="_hHqJYEc">We included RCT assessing participants diagnosed with asthma and/or COPD who had undergone a digital health intervention compared with standard of care.</s><s xml:id="_NDXx4t9">To be included, primary studies were required to conduct an economic evaluation of the digital health intervention.</s><s xml:id="_rudPnEJ">No restrictions were made about the date or language of the studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2" xml:id="_Qvjtcdn">| Search Strategy</head><p xml:id="_tfQ3TbV"><s xml:id="_XeXnM4d">The systematic review started on 1 July 2023.</s></p><p xml:id="_tGhk48h"><s xml:id="_BdpwSBx">To identify eligible studies, the following electronic bibliographic databases were searched: PubMed, Scopus and Web of Science.</s><s xml:id="_QJb7wHQ">Table <ref type="table">S1</ref> contains the search strategy created for PubMed and subsequently adapted for the other databases.</s><s xml:id="_ZXd5KDt">The Cochrane highly sensitive strategy for RCT was used for the RCT component of the query.</s><s xml:id="_QbUU2hg">The search was conducted on August 2023.</s><s xml:id="_FeFW2nc">exclusion recorded and presented in File S2.</s><s xml:id="_eCsgcgv">Disagreements were resolved through consensus, and a third reviewer arbitrated in cases where discrepancies remained unresolved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4" xml:id="_BM7fQ9X">| Data Extraction</head><p xml:id="_q5xuNRy"><s xml:id="_BycCRvQ">A data extraction form was purposely built for this study.</s><s xml:id="_hz8SqHb">Study variables extracted included: publication year, funding sources, country, institution, inclusion criteria, methods for asthma or COPD diagnosis, description of the intervention, intervention duration, electronic equipment used, variables registered by the equipment, type of telemedicine, main outcomes, differences in outcomes, type of costs evaluated, type and year of currency, costs associated with the intervention and with standard of care, if available, incremental cost-effectiveness and QALYs, when applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5" xml:id="_UJ7X5hV">| Risk of Bias</head><p xml:id="_qmEXRYm"><s xml:id="_vHGZRuw">Two reviewers utilised the Revised Cochrane risk-of-bias tool for randomised trials (RoB2) to independently assess the quality of eligible studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6" xml:id="_MqcNuxA">| Synthesis Methods</head><p xml:id="_Cw7gmmy"><s xml:id="_eY7kDeX">All cost data are presented in Euro of 2024.</s><s xml:id="_BMhwm5K">When needed, we performed currency conversion and inflation adjustment.</s><s xml:id="_cCc7wJa">All effectiveness data are presented in QALY.</s><s xml:id="_D4u4X5a">For studies presenting data on both costs and effectiveness, we calculated incremental cost-effectiveness ratios (ICER); otherwise, we expressed results as cost differences.</s><s xml:id="_bd2TJWQ">We did not perform meta-analysis due to the diversity of interventions in the included primary studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3" xml:id="_Jrspdd8">| Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1" xml:id="_T42Sbhj">| Study Characteristics</head><p xml:id="_z8Nu3uY"><s xml:id="_6Akeutg">We identified a total of 1100 records through database searching.</s><s xml:id="_Q3r3zKy">After duplicate removal, 676 records were screened by title and abstract, of which 112 were assessed by full text reading.</s><s xml:id="_wYFXAhA">A total of 35 primary studies were included in the systematic review.</s><s xml:id="_6V29MBC">Table <ref type="table">1</ref> presents the characteristics of the included studies.</s><s xml:id="_BfErAaj">The included studies assessed a total of 33,781 participants (the sample size ranged from 16 to 14,978 participants).</s><s xml:id="_dtnaXjF">A total of 21 studies were related to COPD , 13 related to asthma <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref> and 1 related to both diseases <ref type="bibr" target="#b40">[41]</ref>.</s><s xml:id="_gS4hrba">The studies were conducted between the years 2001 and 2021.</s><s xml:id="_jTnXGvE">The majority of the studies were conducted in Europe, with only four studies conducted in Oceania, two in Asia and five in America.</s><s xml:id="_fY7EXfz">Participants' mean ages ranged from 6 to 73 years.</s></p><p xml:id="_UBdeh82"><s xml:id="_Pgd9tYr">Overall, studies utilised four categories of digital health intervention: (i) Electronic patient diaries (n = 4), (ii) real-time monitoring (n = 19), (iii) teleconsultations (n = 6) and (iv) others (n = 6), including SMS reminders, web platforms, video interventions and encouragement phone calls.</s><s xml:id="_3uta5th">The reported time horizons ranged from 3 to 32 months.</s></p><p xml:id="_fuSJNQX"><s xml:id="_UNH2kN8">Regarding the electronic equipment used, 23 used peripheral devices, such as pulse oximeters, blood pressure cuffs, weight scales, spirometers, pedometers, thermometers, glucometers and an oxygen source.</s><s xml:id="_vbxdwdm">Ten studies used only a mobile phone with no additional devices to perform the intervention.</s><s xml:id="_bvTgTnh">In relation to the collected data parameters, the amount of simultaneously monitored parameters ranged from one to eight.</s><s xml:id="_6d22sSN">Ten studies used smart devices to send SMS (n = 3) or to call participants (n = 7).</s><s xml:id="_vfBXggn">Some studies (n = 13) gave participants smart devices so that</s></p><p xml:id="_MQbnawy"><s xml:id="_cJZ4RfZ">TABLE 1 | Characteristics of the included primary studies.</s><s xml:id="_SCT5A6h">Study Diagnosis Inclusion criteria Sample size Mean age of participants Description of the intervention Type of digital health Soriano J. B., 2018 [15] COPD Adults (50-90 years) with FEV1 &lt; 50% and treated with chronic home oxygen therapy 229 participants 71 years Participants took physiological measurements using a telehealth equipment, daily for 12 months Real-time monitoring McDowell J. E., 2015 [16] COPD Adults with COPD GOLD 2 or 3 100 participants 70 years Patients took daily physiological measurements and answered questions relating to symptoms, using a home telehealth system-HomMed-for 6 months Real-time monitoring Xu C., 2010 [35] Asthma Children with an acute exacerbation requiring oral steroid rescue in the previous 12 months 121 participants 7 years Participants received an automated phone call twice a week for 6 months to answer questions about asthma symptoms and medication use Real-time monitoring Shdaifat M. B., 2021 [36] Asthma Children with moderate to severe uncontrolled asthma, using metered dose inhalers 90 participants 7.70 years Participants received a video-call session to access their inhaler technique every 4 weeks for a period of 3 months Teleconsultations Paré G., 2013 [17] COPD Adults with FEV1 &lt; 45% and hospitalised at least once in the previous year 120 participants 68 years Participants answered questions about symptoms and medication use, using a telehealth equipment (TELUS) for 6 months Real-time monitoring Henderson C., 2013 [18] COPD, heart failure and diabetes Adults with one of three longterm index conditions: chronic obstructive pulmonary disease, heart failure or diabetes 965 participants (232 with COPD) 70 years Participants took physiological measurements, using a telemonitoring equipment for 12 months Real-time monitoring Willems D. C. M., 2007 [37] Asthma Adults and children &gt;7 years with an asthma severity stage I-III of Gina guidelines 102 participants 45,8 years in the adult group and 10,71 years in the children group Participants performed daily lung function tests for 12 months Real-time monitoring van der Meer V., 2011 [38] Asthma Adults with a prescription of inhaled corticosteroids for at least 3 months in the previous year 200 participants 37 years Participants used a web site to complete an electronic version of the Asthma Control Questionnaire weekly for 12 months Web platform (Continues) Study Diagnosis Inclusion criteria Sample size Mean age of participants Description of the intervention Type of digital health Udsen F. W., 2017 [19] COPD Adults with (mMRC) ≥2 or mMRC ≥3 and CAT ≥10, who had at least two exacerbations within the previous 12 months 751 patients 69.9 years Participants took physiological measurements weekly by 12 months, using a telehealth equipment.</s><s xml:id="_8aKXPJf">The equipment also had information about handling COPD Real-time monitoring Pinnock H., 2004 [39] Asthma Adults who had asked for a bronchodilator inhaler prescription in the previous 6 months but who had not had a routine asthma review in the preceding 11 months 278 participants 55.5 years Participants received phone calls from an asthma nurse to review their asthma control, for a period of 3 months Teleconsultations Jódar-Sánchez F., 2014 [14] COPD Adults with long-term oxygen therapy indication, with at least one hospitalisation for respiratory illness in the previous year and clinically stable for 3 months 45 participants 72,5 years Participants measured their vital signs every weekday for 4 months Real-time monitoring Haesum L. K. E., 2012 [20] COPD Adults with COPD GOLD III or IV 105 participants 68 years Participants took physiological measurements for a period of 4 months, using a telehealth monitoring device Real-time monitoring Vasbinder E. C., 2016 [8] Asthma Children that use a ICS for at least 3 months and pressurised metered dose inhaler (pMDI) 209 participants 7.8 years Participants had a Real Time Medication Monitoring device that registered all ICS inhalations using the pMDI for 12 months.</s><s xml:id="_5RZBm6Y">They received text messages if a dose was not registered SMS reminders Clemente P. M., 2020 [21] COPD Adults with COPD exacerbation and arterial gasometry: pH &gt; 7.35, pO 2 &gt; 50 mmHg, with O 2 at a maximum of 3 lpm, and oxygen saturation &gt; 90%, pCO 2 &lt; 55 116 participants 69 years Participants transmitted physiologic measurements twice per day for 6 months and received a phone call from a physician to evaluate symptoms Teleconsultations Duiverman M. L., 2019 [22] COPD Adults with COPD GOLD III or IV with no COPD exacerbation during the last 4 weeks, and a pH &gt; 7.35 67 participants 63.4 years Participants initiated chronic noninvasive ventilation at home, using telemedicine.</s><s xml:id="_mM46KNP">PtCO2 and ventilator data were sent to the hospital.</s><s xml:id="_xz48rPp">The intervention period was 6 months Real-time monitoring TABLE 1 | (Continued) (Continues) Study Diagnosis Inclusion criteria Sample size Mean age of participants Description of the intervention Type of digital health Farrero E., 2001 [23] COPD Adults requiring long-term oxygen therapy for at least 6 months 120 participants 69 years Participants received a monthly telephone call for 12 months to detect changes in respiratory symptoms Teleconsultations Ostojic V., 2005 [40] Asthma Moderate persistent asthma and treatment with ICS and LABA 16 participants 24.6 years Participants sent their PEF results daily for 16 weeks.</s><s xml:id="_UbQUbka">They received weekly instructions by SMS with therapy adjustments and recommended follow-up Electronic patient diaries Vitacca M., 2009 [24] Chronic respiratory failure, including COPD Adults needing home mechanical ventilation (HMV) and/or longterm oxygen therapy (LTOT) 240 participants 61.2 years Participants received follow-up phone calls for 12 months to answer questions from a clinical scoring system-Respicard Teleconsultations Kenealy T. W., 2015 [25] COPD Adults permanently living in the Counties Manukau DHB region or in the Canterbury DHB region 48 participants 67 years Participants took physiological measurements and answered preprogrammed diseasespecific questions, using a health-hub for 12 months Real-time monitoring San Miguel, K., 2013 [26] COPD Adults receiving domiciliary oxygen 80 participants 72,5 years Participants measured their vital signs and answered questions relating to their general state of health, daily for 6 months Real-time monitoring Stoddart A., 2015 [27] COPD Adults with an hospital admission for a COPD exacerbation in the previous year 256 participants 68.9 years Participants answered daily symptoms and medication use questionnaires and took physiological measurements for 12 months Real-time monitoring Walker P., 2018 [28] COPD Adults (&gt;60 years) with COPD GOLD II or higher, exacerbation in the previous 12 months, smoking history of &gt;10 pack-years and at least one nonpulmonary chronic condition 312 participants 71 years Participants used the CHROMED monitoring platform daily for 9 months to measure within-breath respiratory mechanical impedance using forced oscillation technique (FOT) Real-time monitoring Dinesen B., 2012 [29] COPD Adults with COPD GOLD III or IV 111 participants 68 years Participants took physiological measurements every week for 10 months Real-time monitoring Bentley C. L., 2014 [30] COPD Adults with 1, 2 or 3 hospital admissions for COPD exacerbations in the previous 12 months 63 participants 66.6 years Participants took physiological measurements daily for 8 months, using a telehealth equipment Real-time monitoring TABLE 1 | (Continued) (Continues) 13652222, 2024, 9, Downloaded from <ref type="url" target="https://onlinelibrary.wiley.com/doi/10.1111/cea.14547">https://onlinelibrary.wiley.com/doi/10.1111/cea.14547</ref></s><s xml:id="_54rp7JK">by University Of Iowa Libraries -Serials Acquisitions, Wiley Online Library on [21/02/2025].</s><s xml:id="_wQTFydt">See the Terms and Conditions (<ref type="url" target="https://onlinelibrary.wiley.com/terms-and-conditions">https://onlinelibrary.wiley.com/terms-and-conditions</ref>)</s><s xml:id="_mbQbNgE">on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License Study Diagnosis Inclusion criteria Sample size Mean age of participants Description of the intervention Type of digital health Waterhouse J. C., 2010 [31] COPD Medical Research Council (MRC) grade 3 or worse dyspnoea despite optimal medical care and clinically stable for at least 4 weeks 161 participants -Participants received an exercise encouragement phone call 1 month post pulmonary rehabilitation and at monthly intervals for 6 months Encouragement phone calls Wagner N. M., 2012 [41] Asthma Adults with intermittent or persistent asthma 14,978 participants 49 years Participants received a text message with a link to answer a single question from the asthma control test (ACT).</s><s xml:id="_GXEwMrJ">This intervention period was 18 months Electronic patient diaries Van Den Wijngaart L. S., 2017 [42] Asthma Children with asthma and at least one allergy for airborne allergens 210 participants 11.3 years Participants answered a children asthma control test (C-ACT) monthly for 16 months, using a web platform Web platforms Esteban C., 2021 [32] COPD Adults with least two admissions for exacerbation in the previous year or at least three in the previous 2 years and stable for 6 months 163 participants 70 years Participants submit information about their clinical condition daily for 2 years, using a smartphone with specific software Electronic patient diaries Shoup J. A., 2015 [47] Asthma or COPD Adults (19-64 years) with a diagnosis of asthma or COPD 12,285 participants -Participants received an interactive voice response reminder to take an influenza vaccine SMS reminders Koff P. B., 2009 [33] COPD Adults with COPD GOLD III or IV 40 participants 65.8 years Participants took physiological measurements daily for 3 months, using a digital health equipment (Heath Buddy System) Real-time monitoring Thomas M., 2017 [43] Asthma Adults with impaired asthma-related health status (Asthma Quality of Life Questionnaire (AQLQ) score of &lt;5.5) 655 participants 56 years Participants received a DVD with explanation and illustration of how to carry out breathing exercises and motivational components.</s><s xml:id="_MTfVRAF">The intervention period was 12 months DVD Jacobson J. S., 2009 [44] Asthma Children (8-17 years) who had 2 or more emergency department visits or 1 hospitalisation in the previous year 59 participants -Participants answered daily questions about their symptoms and use of medications for a period of 32 months Real-time monitoring Gruffydd-Jones K., 2005 [45] Asthma Adults (17-70 years) with asthma 194 participants -Participants received a phone call every 6 months for 12 months to answer the Royal College of Physicians's questions to assess asthma morbidity Teleconsultations TABLE 1 | (Continued) (Continues)</s></p><p xml:id="_nvmAmtu"><s xml:id="_vU3fgJF">they could respond to disease-specific questionnaires, regarding their symptoms and medication use.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2" xml:id="_QkfV2mu">| Risk of Bias</head><p xml:id="_jghYvCY"><s xml:id="_qzjJ5eC">A total of five studies were judged to be at a high risk of bias, mainly because of concerns about the randomisation process and/or deviations from the intended interventions and/ or missing outcome data.</s><s xml:id="_3fdqkyP">Seventeen studies were judged to raise some concerns, mainly due to missing outcome data.</s></p><p xml:id="_BRkt2cM"><s xml:id="_5HAkXnH">The remaining studies were considered to be of low risk of bias (Figure <ref type="figure" target="#fig_0">2</ref>).</s><s xml:id="_gVVWtNS">File S3 includes all RoB2 scoring sheets of the included studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3" xml:id="_GauM9BT">| Economic Analysis</head><p xml:id="_kwS32mb"><s xml:id="_8NNKNU6">Eleven studies performed a full economic evaluation analysis, reporting the cost-effectiveness or cost-utility of the digital health intervention.</s><s xml:id="_X7PWmGG">The remaining 24 studies performed a partial economic analysis, only comparing the costs between a digital intervention and the standard of care.</s><s xml:id="_c6G2Rfm">Table <ref type="table" target="#tab_3">2</ref> describes the economic perspective of each study, the intervention period, the type of costs evaluated, the costs and the difference in QALYs (Quality-Adjusted Life Years) (when applicable) of the digital health intervention and of the standard of care and the ICER (when applicable).</s><s xml:id="_7pQvwNb">All values are presented in Euro of 2024.</s></p><p xml:id="_DtuWSg5"><s xml:id="_mszWn8u">Eleven studies only adopted the healthcare perspective, eight adopted the societal perspective (with seven of them also adopting the healthcare perspective) and the remaining studies (n = 18) did not clarify the adopted perspective.</s><s xml:id="_fkEBvaG">The societal perspective considers the costs to be incurred by all stakeholders of the society, as opposed to the healthcare perspective that only considers the costs that the healthcare system needs to bear (excluding, therefore, items such as out-of-pocket costs paid by patients or indirect costs associated with productivity losses).</s><s xml:id="_TBSjkEr">Table <ref type="table">3</ref> presents the economic perspective adopted in each study and the type of economic analysis performed.</s></p><p xml:id="_2UTJ6RG"><s xml:id="_DUxVAuN">Considering the studies whose interventions consisted of electronic patient diaries (n = 4), only one <ref type="bibr" target="#b31">[32]</ref> performed a full economic analysis and concluded that the digital health intervention was not cost-effective (less costs but also lower amount of QALY).</s><s xml:id="_wy5Uwvc">However, in this study, if the reference was the intervention group, the ICER would be 228435.6€/QALY.</s><s xml:id="_XMeFCYT">This was the only study in this group that involved COPD participants.</s><s xml:id="_a2dtW2x">The remaining studies assessed patients with asthma and performed partial economic analyses.</s><s xml:id="_cpu8zsD">Only one of those studies <ref type="bibr" target="#b39">[40]</ref> concluded that the digital intervention was more costly than the standard of care (leading to an additional weekly cost of 2.52€ per patient).</s><s xml:id="_gyU7wMS">This is the only study in this group that has low risk of bias.</s><s xml:id="_9vbRrvB">The other two studies concluded that the digital intervention was less costly, with one <ref type="bibr" target="#b40">[41]</ref> reporting a weekly difference of 1.47€ per patient between interventions and the other <ref type="bibr" target="#b45">[46]</ref> reporting a weekly difference of 0.68€ between the intervention and the standard of care groups.</s></p><p xml:id="_8U9eHGa"><s xml:id="_eybdDpR">Among studies that used teleconsultations as a digital health in-</s></p><p xml:id="_NATkBgs"><s xml:id="_jfCZvRD">tervention, five provided phone calls to participants to inquire Study Diagnosis Inclusion criteria Sample size Mean age of participants Description of the intervention Type of digital health Lv S., 2019 [46] Asthma Children with positive asthma predictive index and willing and capable to correctly use an inhaler 152 participants 7.95 years Participants used a smartphone application that helped them manage their disease.</s><s xml:id="_PNAvbV7">The intervention period was 12 months Electronic patient diaries Shany T., 2016 [34] COPD Adults with at least one hospital admission for a COPD exacerbation in the previous year 42 participants 73.2 years Participants took physiological measurements and answered question related to their symptoms, using a digital health equipment, for 12 months Real-time monitoring TABLE 1 | (Continued) 13652222, 2024, 9, Downloaded from <ref type="url" target="https://onlinelibrary.wiley.com/doi/10.1111/cea.14547">https://onlinelibrary.wiley.com/doi/10.1111/cea.14547</ref></s><s xml:id="_eTVVv3r">by University Of Iowa Libraries -Serials Acquisitions, Wiley Online Library on [21/02/2025].</s><s xml:id="_Bwt9CEh">See the Terms and Conditions (<ref type="url" target="https://onlinelibrary.wiley.com/terms-and-conditions">https://onlinelibrary.wiley.com/terms-and-conditions</ref>)</s><s xml:id="_hrQbkdH">on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</s></p><p xml:id="_J38MYaS"><s xml:id="_mjFpd4V">on disease-related symptoms <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b44">45]</ref> and one provided video-call meetings <ref type="bibr" target="#b35">[36]</ref>.</s><s xml:id="_3AYpYMA">All the studies in this group conducted a partial economic analysis and concluded that the digital intervention was less costly than the standard of care.</s><s xml:id="_ZFXr4CC">Half of the studies involved asthma participants <ref type="bibr" target="#b35">[36,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b44">45]</ref>, and the other half involved COPD participants <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s xml:id="_zpsSPqN">In this group, only one study is considered of low risk of bias <ref type="bibr" target="#b35">[36]</ref>.</s></p><p xml:id="_2qJzU9D"><s xml:id="_FaE7bcw">Considering the group of studies that used real-time monitoring (n = 19), eight performed a full economic analysis [14, 16,   <ref type="bibr">18-20, 27, 30, 37, 39]</ref>.</s><s xml:id="_BBK35HQ">Of these, one study <ref type="bibr" target="#b19">[20]</ref> involved COPD participants and concluded that the digital health intervention was cost-effective, presenting an ICER of 14612.42€/QALY.</s><s xml:id="_ANafH7e">Another study <ref type="bibr" target="#b29">[30]</ref>, also involving COPD participants, reported that the intervention was only cost-effective when considering the societal perspective (ICER of 3530,93€/QALY).</s><s xml:id="_xrBRvmq">In turn, another study <ref type="bibr" target="#b36">[37]</ref> involved children and adults with asthma and concluded that the digital intervention was only cost-effective when considering the healthcare perspective in adults (ICER of 24,739€/QALY).</s><s xml:id="_TtH4xmk">The other studies assessed participants with COPD and concluded that digital health interventions were not cost-effective, presenting ICER ranging from 49,966€/QALY to 286,369,28€/QALY.</s><s xml:id="_T2WZrFn">There were 11 studies on real-time monitoring that conducted a partial economic analysis.</s><s xml:id="_NgNzPap">All studies except one <ref type="bibr" target="#b43">[44]</ref> concluded that the digital health intervention was less costly than the standard of care (cost differences ranging from 97.62€ to 7424.1€).</s><s xml:id="_zA6djwK">Of these studies, all but two <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b43">44]</ref> included COPD participants.</s><s xml:id="_xwNn7UQ">Among the low risk of bias studies in this group, four concluded that the intervention was economically favourable <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b28">29]</ref> and two reported opposite results <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b18">19]</ref>.</s></p><p xml:id="_EpwqBHb"><s xml:id="_z4ecdFb">The remaining studies (not included in any of the above categories) involved the use of SMS reminders, video interventions, web platforms and exercise encouragement phone calls (n = 6).</s><s xml:id="_yyabYM4">Two studies in this group performed a full economic analysis.</s></p><p xml:id="_fw7eQcb"><s xml:id="_MCknfjG">One study <ref type="bibr" target="#b30">[31]</ref> included COPD participants and compared the use of encouragement phone calls with routine face-to-face follow-up, in the hospital and in the community setting, concluding that the digital health intervention was cost-effective only when considering the community setting (ICER of 21,071€/QALY).</s><s xml:id="_UgQUshY">In the other study <ref type="bibr" target="#b42">[43]</ref>, asthma participants received a DVD with explanation and illustration of how to carry out breathing exercises and motivational components.</s><s xml:id="_4R9MjKv">This intervention was considered cost-effective, with an ICER of 4738€/QALY.</s><s xml:id="_GSuRKgG">The remaining studies in this group performed only a partial economic analysis.</s><s xml:id="_sRYyAes">Two studies, one <ref type="bibr" target="#b7">[8]</ref> including asthma participants and the other <ref type="bibr" target="#b46">[47]</ref> including both asthma and COPD participants, used text messages to remind participants to take their medication or to take an influenza vaccine and both concluded that this intervention was more expensive than the standard of care.</s><s xml:id="_JEKPCcJ">The remaining studies involved participants with asthma using a web platform to answer different versions of the Asthma Control Questionnaire.</s><s xml:id="_twS4Tgc">One study <ref type="bibr" target="#b37">[38]</ref> assessed adults and concluded that this intervention was more expensive than the standard of care and another study <ref type="bibr" target="#b41">[42]</ref> assessed children and considered the intervention 219.02€ less costly than the standard of care.</s><s xml:id="_WYPGsnU">Among the low risk of bias studies in this group, two concluded that the intervention was economically favourable <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b41">42]</ref> and three reported opposite results <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b46">47]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4" xml:id="_FtZXyDU">| Discussion</head><p xml:id="_yPQ5qSv"><s xml:id="_ZB384nB">To the best of our knowledge, this is the first systematic review that attempted to analyse the cost-effectiveness of digital health interventions in the management of patients with asthma and/or COPD.</s><s xml:id="_Y5vDeef">We included <ref type="bibr" target="#b34">35</ref>  As demonstrated, the cost-effectiveness of an intervention largely depends on the willingness-to-pay threshold of each country, the healthcare organisation and also on the type of intervention and follow-up period.</s><s xml:id="_P53U7s6">This makes it difficult to generalise results and to extract robust conclusions.</s><s xml:id="_wae4qsf">However, our findings overall suggest that most studies consider the digital health intervention economically favourable.</s></p><p xml:id="_6bEVqXg"><s xml:id="_8ZJzgkR">Previous systematic reviews on cost-effectiveness of digital health interventions in other chronic conditions have applied a wide set of different methodologies.</s><s xml:id="_2v96XNc">Nevertheless, in recent reviews, the most frequently reported type of digital health intervention used was video-conferencing <ref type="bibr" target="#b47">[48,</ref><ref type="bibr" target="#b48">49]</ref>.</s><s xml:id="_DdxgyNA">By contrast, for asthma and COPD, real-time monitoring was the most frequent type of assessed intervention.</s><s xml:id="_aFk8bTb">This may be due to the fact that in asthma and COPD, the priority is to prevent exacerbations, rather than to provide scheduled consultations.</s><s xml:id="_RYgRpfY">As with this systematic review on asthma and COPD, systematic reviews on other chronic diseases tend to conclude that digital health interventions have a positive economic impact.</s><s xml:id="_HHNPhMN">However, they also agree that the generalisability of the results is complex and limited due to discrepancies in the modality of equipment used, cost items examined and type of economic analysis performed.</s></p><p xml:id="_R9u9SB7"><s xml:id="_BsSwsS7">In our review, most included primary studies concluded that digital interventions are economically favourable since not only they are typically not expensive but also they have the potential to reduce exacerbations, leading to a reduction in costs related to nonscheduled primary care visits, emergency department visits, hospital admissions, medication use and work absenteeism.</s><s xml:id="_r9DrrG3">This is in line with studies related to other conditions prone to exacerbations, such as diabetes mellitus or heart failure <ref type="bibr" target="#b49">[50]</ref>.</s></p><p xml:id="_eycSnU3"><s xml:id="_8FhDHAd">Only six studies <ref type="bibr">[8, 35-37, 42, 46]</ref> included children as participants.</s><s xml:id="_J6Zp3ev">Most of them conducted a partial economic analysis, and all but two <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b36">37]</ref> concluded that the intervention was less costly than the standard of care.</s></p><p xml:id="_AD8v2xt"><s xml:id="_srURf98">Whether an intervention is cost-effective depends on the willingness-to-pay threshold of each country, so the results may vary considering the income of the country in study.</s><s xml:id="_bvK6ydV">Future research should focus on understudied contexts, such as low-income countries and rural societies.</s><s xml:id="_HwqkpFN">In fact, in these settings, patients may have more have limited access to health care and/or to Internet and more limited digital skills <ref type="bibr" target="#b49">[50]</ref>.</s></p><p xml:id="_vDPW4Cw"><s xml:id="_xDqT3hc">Providing access to digital hardware and advocating for digital literacy is essential, especially in a generation willing to invest in digital tools in health care.</s><s xml:id="_tXT4dJJ">Furthermore, costs of acquiring the equipment are one of the most relevant items that increases total costs of the intervention, so future research should also report longer intervention periods, as the costs of the digital equipment tend to decrease with prolonged usage <ref type="bibr" target="#b50">[51]</ref>.</s><s xml:id="_BNBqA65">Finally, future research may also preferentially consist on complete economic evaluation analyses rather than partial economic studies.</s></p><p xml:id="_ungEfs9"><s xml:id="_CQsyMc9">Our review has some limitations.</s><s xml:id="_ywVppN7">Firstly, studies were very diverse in terms of costs evaluated and intervention period analysed, limiting the comparisons we were able to perform.</s><s xml:id="_4evD2KM">Secondly, the majority of the studies raised some concerns in terms of risk of bias mainly due to missing outcome data.</s><s xml:id="_HaC3xXw">Thirdly, most of the studies were conducted in high-income countries, so our findings may not be generalised to low and middle-income countries.</s><s xml:id="_RTmVNwZ">Additionally, most of the studies included in this review are more than 10 years old, potentially not reflecting the most recent technological developments.</s><s xml:id="_3N4yGtk">Finally, many primary studies were not full economic evaluation studies, but only compared the costs of the digital health intervention versus standard of care.</s><s xml:id="_NWVPBuj">A full economic analysis takes into account the costs and the consequences/outcomes of an intervention, while a partial analysis only considers the costs of the intervention.</s><s xml:id="_QFbVyzG">Having conducted a full economic evaluation study would be particularly relevant in cases which the digital health intervention was found to be more costly than the standard of care (in order to assess whether the society would be willing to pay for the additional costs considering the expected additional gains in health outcomes).</s></p><p xml:id="_xWmgggx"><s xml:id="_fA94cpW">This systematic review has also some strengths.</s><s xml:id="_gpKP8ZE">Firstly, we encompassed a broad set of digital health interventions, allowing us to assess the costs and cost-effectiveness of teleconsultations, electronic patient diaries and real-time monitoring interventions.</s><s xml:id="_AvufTFr">We included only RCT, which are less prone to confounding (particularly for the assessment of the consequences of interventions) than observational studies <ref type="bibr" target="#b51">[52]</ref>.</s><s xml:id="_dYE36Hw">Our literature research comprised three different electronic bibliographic databases, and we did not use exclusion criteria based on the date or language of publication.</s><s xml:id="_WyKZmkb">Finally, the articles were screened and selected by two reviewers, with disagreements being resolved through consensus or through a third reviewer in cases where discrepancies remained unresolved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5" xml:id="_KCZZwuM">| Conclusion</head><p xml:id="_b6WdCUn"><s xml:id="_H7FPJ7V">Our study gives preliminary findings about the cost-effectiveness of digital health interventions in the management of asthma and/or COPD.</s><s xml:id="_mn6vNpP">We have stratified the studies by the type of digital intervention used, in order to provide a more useful resource for practice, research and decision-making.</s><s xml:id="_V7qQX5y">Most studies suggest that these interventions are favourable from an economic point of view, particularly when referring to teleconsultations and real-time monitoring in adult patients.</s><s xml:id="_yQEskdp">Despite having more studies involving COPD patients, in both asthma and COPD most assessed digital health interventions seem to be associated with less costs (or with small increases in costs) and higher health-related quality-of-life.</s><s xml:id="_7Mxz49T">However, an effort should be made to conduct more high-quality studies, since most of the studies included in this review are more than 10 years old and consist of partial economic analyses.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 2 |</head><label>2</label><figDesc><div><p xml:id="_8yBXVvQ"><s xml:id="_Xqvw8SP">FIGURE 2 | Quality assessment of the included studies (RoB2 tool).</s></p></div></figDesc><graphic coords="9,133.26,34.02,328.29,605.41" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="3,133.26,34.02,328.75,253.15" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>TABLE 2 |</head><label>2</label><figDesc><div><p xml:id="_cdjECsK"><s xml:id="_hTfTuYk">Summary of the characteristics of the included primary studies on health economic evaluation variables.</s><s xml:id="_fxBDS97">Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/cea.14547</s><s xml:id="_RUDQ5Hr">by University Of Iowa Libraries -Serials Acquisitions, Wiley Online Library on [21/02/2025].</s><s xml:id="_Du6XpyR">See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions)</s><s xml:id="_25GuzKf">on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>ICER</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>279,343€/QALY</cell><cell></cell><cell></cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>-</cell><cell></cell><cell></cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>163,760€/QALY</cell><cell>Adults: 24739€</cell><cell>(healthcare),</cell><cell>49,966€</cell><cell>(societal);</cell><cell>Children: 94548€</cell><cell>(healthcare),</cell><cell>95,104€ (societal)</cell><cell>(Continues)</cell></row><row><cell></cell><cell>Difference</cell><cell>in QALY</cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.01</cell><cell></cell><cell></cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>-</cell><cell></cell><cell></cell><cell>-</cell><cell></cell><cell></cell><cell></cell><cell>0.012</cell><cell>0.03 (adults)</cell><cell>and 0.01</cell><cell>(children)</cell></row><row><cell>Costs of the</cell><cell>standard</cell><cell>intervention</cell><cell>10,969,14€</cell><cell>per patient</cell><cell></cell><cell></cell><cell></cell><cell>-</cell><cell></cell><cell></cell><cell>Not specified</cell><cell>but mentions</cell><cell>a reduction in</cell><cell>healthcare costs</cell><cell>of 432,96€ per</cell><cell>child, compared</cell><cell>with the</cell><cell>control group</cell><cell>276,2€</cell><cell></cell><cell></cell><cell>5174,52€ per</cell><cell>patient</cell><cell></cell><cell></cell><cell>9613,78€</cell><cell>3136,28€</cell><cell>(adult group)</cell><cell>and 961,17€</cell><cell>(children group)</cell></row><row><cell></cell><cell>Costs of the digital</cell><cell>health intervention</cell><cell>9731,76€ per patient</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>2530,39€ per patient</cell><cell></cell><cell></cell><cell>129,23€</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>163,1€</cell><cell></cell><cell></cell><cell>3851,13€ per patient</cell><cell></cell><cell></cell><cell></cell><cell>11,589,58€</cell><cell>4786,53€ (adult group) and</cell><cell>1941,66€ (children group)</cell></row><row><cell></cell><cell></cell><cell>Costs evaluated</cell><cell>Non-scheduled visits to primary</cell><cell>care services, emergency visits to</cell><cell>primary care, hospital emergency</cell><cell>room visits, pulmonologist visits</cell><cell>and hospital admissions</cell><cell>Telemonitoring equipment,</cell><cell>primary care visits, secondary</cell><cell>care visits and other NHS costs</cell><cell>Emergency department visits,</cell><cell>hospital admission, general</cell><cell>practitioner visits, corticosteroid</cell><cell>course and equipment</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Medication, private clinic visits,</cell><cell>transportation, parent absenteeism</cell><cell>and hospitalisation burdens</cell><cell>Nurse and respiratory</cell><cell>therapists visits, transport,</cell><cell>hospitalisations, emergency</cell><cell>room visits and equipment</cell><cell>Equipment, healthcare utilisation,</cell><cell>project management and central</cell><cell>telehealth monitoring teams</cell><cell>Healthcare costs, patient and</cell><cell>family costs, costs associated</cell><cell>with productivity losses</cell></row><row><cell></cell><cell>Economic</cell><cell>perspective</cell><cell>-</cell><cell>[12 months]</cell><cell></cell><cell></cell><cell></cell><cell>-</cell><cell>[6 months]</cell><cell></cell><cell>Healthcare</cell><cell>[6 months]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>-</cell><cell>[3 months]</cell><cell></cell><cell>Healthcare</cell><cell>[6 months]</cell><cell></cell><cell></cell><cell>Healthcare</cell><cell>and societal</cell><cell>[12 months]</cell><cell>Healthcare</cell><cell>and societal</cell><cell>[12 months]</cell></row><row><cell></cell><cell></cell><cell>Study</cell><cell>Soriano J. B., 2018 [15]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>McDowell J. E., 2015 [16]</cell><cell></cell><cell></cell><cell>Xu C., 2010 [35]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Shdaifat M. B., 2021 [36]</cell><cell></cell><cell></cell><cell>Paré G., 2013 [17]</cell><cell></cell><cell></cell><cell></cell><cell>Henderson C., 2013 [18]</cell><cell>Willems D. C. M., 2007 [37]</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>TABLE 2 |</head><label>2</label><figDesc><div><p xml:id="_cuvH6ha"><s xml:id="_fyZMjfv">RCT, most of which included only adult participants.</s><s xml:id="_2TGpWYy">We observed that the most frequently assessed type of digital intervention in the included studies involved real-time collection of clinical data Study (Continued) using peripheral equipment.</s><s xml:id="_fnFpyPg">The studies involving real-time monitoring or teleconsultations mostly presented results indicating that digital health interventions were economically more favourable, even though most of these studies performed only a partial economic analysis.</s><s xml:id="_3RF8Juh">The results obtained from other digital interventions (such as electronic patient diaries, text messages or web platforms) reported contradictory results.</s><s xml:id="_YYM4SA5">However, each of these interventions was assessed by a smaller amount of studies.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>ICER</cell><cell>-</cell><cell></cell><cell>4738€/QALY</cell><cell></cell><cell></cell><cell></cell><cell>-</cell><cell></cell><cell>-</cell><cell></cell><cell>-</cell></row><row><cell></cell><cell>Difference</cell><cell>in QALY</cell><cell>-</cell><cell></cell><cell>0.02</cell><cell></cell><cell></cell><cell></cell><cell>-</cell><cell></cell><cell>-</cell><cell></cell><cell>-</cell></row><row><cell>Costs of the</cell><cell>standard</cell><cell>intervention</cell><cell>15,997,22€</cell><cell></cell><cell>551,8€ per</cell><cell>patient</cell><cell>1146,33€</cell><cell></cell><cell>671,34€ per</cell><cell>patient</cell><cell>165,06€</cell><cell></cell><cell>475,35€</cell></row><row><cell></cell><cell>Costs of the digital</cell><cell>health intervention</cell><cell>8573,12€</cell><cell></cell><cell>463,22€ per patient</cell><cell></cell><cell>5441,19€</cell><cell></cell><cell>422,1€ per patient</cell><cell></cell><cell>130,34€</cell><cell></cell><cell>377,73€</cell></row><row><cell></cell><cell></cell><cell>Costs evaluated</cell><cell>Costs of hospital contacts</cell><cell></cell><cell>Costs of medication, equipment and</cell><cell>hospital and primary care contacts</cell><cell>Costs of hospital contacts</cell><cell></cell><cell>Costs of medication, nurse</cell><cell>time and hospital contacts</cell><cell>Costs of medical expenses</cell><cell></cell><cell>Cost of hospital contacts</cell><cell>and patient time</cell></row><row><cell></cell><cell>Economic</cell><cell>perspective</cell><cell>-</cell><cell>[3 months]</cell><cell>Healthcare</cell><cell>[12 months]</cell><cell>-</cell><cell>[32 months]</cell><cell>Healthcare</cell><cell>[12 months]</cell><cell>-</cell><cell>[12 months]</cell><cell>-</cell><cell>[12 months]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Koff P. B., 2009 [33]</cell><cell></cell><cell>Thomas M., 2017 [43]</cell><cell></cell><cell>Jacobson J. S., 2009 [44]</cell><cell></cell><cell>Gruffydd-Jones K., 2005 [45]</cell><cell></cell><cell>Lv S., 2019 [46]</cell><cell></cell><cell>Shany T., 2016 [34]</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_D5HYAFU"><s xml:id="_7qpNUaT">Clinical &amp; Experimental Allergy, 2024</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_Am7mJqm"><s xml:id="_ySEjVCV">13652222, 2024, 9, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/cea.14547</s><s xml:id="_erfwNz6">by University Of Iowa Libraries -Serials Acquisitions, Wiley Online Library on [21/02/2025].</s><s xml:id="_vJhG9kN">See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions)</s><s xml:id="_WM5gTwQ">on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</s></p></note>
		</body>
		<back>


			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_rrvbmxJ">Acknowledgements</head><p xml:id="_HfVPTKP"><s xml:id="_vFN3pD5">The authors have nothing to report.</s></p></div>
			</div>



			<div type="funding">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_GW9AtmG"><p xml:id="_DX4eTfB"><s xml:id="_9dY79kD">The authors received no specific funding for this work.</s></p></div>
			</div>


			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9qzWH5J">Data Availability Statement</head><p xml:id="_vPt65sw"><s xml:id="_W5K884F">Data are available from the authors upon reasonable request.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_WhDk5CH"><p xml:id="_Cr56ac6"><s xml:id="_6jKG8Pq">TABLE <ref type="bibr" target="#b2">3</ref> | Type of economic analysis and perspective adopted by each primary studies.</s><s xml:id="_v6YTDYT">For the perspective, coloured cells indicate the perspective that was chosen, with green indicating favourable results for the digital health intervention and red indicating unfavourable results.</s><s xml:id="_GTm8nBw">Van Den Wijngaart L. S., 2017 <ref type="bibr" target="#b41">[42]</ref> Asthma X Shoup J. A., 2015 <ref type="bibr" target="#b46">[47]</ref> Asthma or COPD X Thomas M., 2017 <ref type="bibr" target="#b42">[43]</ref> Asthma X</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4t3atsC">Study</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6nwyQa8">Diagnosis</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_r8uXGzC">Full economic analysis</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bJD28Vt">Partial economic analysis</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QMs799P">Economic perspective</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GmFkSyE">Cost-benefit</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_nT9Zhvb">Cost-effectiveness</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ntp36vc">Cost-utility</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AkTAcQm">Non-comparative</head><note type="other" xml:id="_mPNh3hp">Comparative</note></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FM3r3vU">Ethics Statement</head><p xml:id="_BBbHXgX"><s xml:id="_SwFamSH">Institutional review board/ethics committee approval and informed consent were not needed as this study doesn't rely on human participants.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_UXc7ZDP">Conflicts of Interest</head><p xml:id="_t6QCMYV"><s xml:id="_gQ4BcEG">The authors declare no conflicts of interest.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AvwMZq5">Supporting Information</head><p xml:id="_YsXRa2t"><s xml:id="_4BGJHVJ">Additional supporting information can be found online in the Supporting Information section.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_yZRrEzP">Telehealthcare for Patients Suffering From Chronic Obstructive Pulmonary Disease: Effects on Health-Related Quality of Life: Results From the Danish &apos;TeleCare North&apos; Cluster-Randomised Trial</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Lilholt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Udsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ehlers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">K</forename><surname>Hejlesen</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2016-014587</idno>
		<ptr target="https://doi.org/10.1136/bmjopen-2016-014587" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_3XnHmBE">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">14587</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">P. H. Lilholt, F. W. Udsen, L. Ehlers, and O. K. Hejlesen, &quot;Telehealth- care for Patients Suffering From Chronic Obstructive Pulmonary Dis- ease: Effects on Health-Related Quality of Life: Results From the Danish &apos;TeleCare North&apos; Cluster-Randomised Trial,&quot; BMJ Open 7, no. 5 (2017): e014587, https:// doi. org/ 10. 1136/ bmjop en-2016-014587.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_5VvRNRr">Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J L</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Aravkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zheng</surname></persName>
		</author>
		<idno type="DOI">10.1002/hon.2936/v1/review1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8dDNTXd">Lancet</title>
		<imprint>
			<biblScope unit="volume">396</biblScope>
			<biblScope unit="issue">10258</biblScope>
			<biblScope unit="page" from="1223" to="1249" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">C. J. L. Murray, A. Y. Aravkin, P. Zheng, et al., &quot;Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019,&quot; Lancet 396, no. 10258 (2020): 1223-1249.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
		<author>
			<orgName type="collaboration">World Health Organization</orgName>
		</author>
		<ptr target="https://www.who.int/news-room/fact-sheets/detail/asthma" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_QHtQ775">Asthma</title>
		<imprint>
			<date type="published" when="2023-05-04">2023 May 4. Dec 15, 2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization, &quot;Asthma,&quot; 2023 May 4 [cited Dec 15, 2023], https:// www. who. int/ news-room/ fact-sheets/ detail/ asthma.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title level="m" type="main" xml:id="_D2U2NSF">Chronic Obstructive Pulmonary Disease (COPD)</title>
		<author>
			<orgName type="collaboration">World Health Organization</orgName>
		</author>
		<idno type="DOI">10.1177/1479972311407218</idno>
		<ptr target="https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd" />
		<imprint>
			<date type="published" when="2023-05-16">2023 May 16. Dec 15, 2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization, &quot;Chronic Obstructive Pulmonary Dis- ease (COPD),&quot; 2023 May 16 [cited Dec 15, 2023], https:// www. who. int/ news-room/ fact-sheets/ detail/ chron ic-obstr uctiv e-pulmo nary-disea se- (copd) .</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main" xml:id="_ckn4qx5">Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease</title>
		<author>
			<orgName type="collaboration">Global Initiative for Chronic Obstructive Lung Disease</orgName>
		</author>
		<idno type="DOI">10.1111/j.1440-1843.2005.00692.x</idno>
		<ptr target="http://goldcopd.org" />
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note>cited Dec 15, 2023</note>
	<note type="raw_reference">Global Initiative for Chronic Obstructive Lung Disease, &quot;Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease,&quot; 2023 [cited Dec 15, 2023], http:// goldc opd. org.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_2vXpKAY">Asthma Costs and Social Impact</title>
		<author>
			<persName><forename type="first">C</forename><surname>Nunes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Morais-Almeida</surname></persName>
		</author>
		<idno type="DOI">10.1186/s40733-016-0029-3</idno>
		<ptr target="https://doi.org/10.1186/s40733-016-0029-3" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_YDXAqyR">Asthma Research and Practice</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">C. Nunes, A. M. Pereira, and M. Morais-Almeida, &quot;Asthma Costs and Social Impact,&quot; Asthma Research and Practice 3, no. 1 (2017): 1, https:// doi. org/ 10. 1186/ s4073 3-016-0029-3.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_TubHUsp">Exacerbations of COPD</title>
		<author>
			<persName><forename type="first">C</forename><surname>Viniol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Vogelmeier</surname></persName>
		</author>
		<idno type="DOI">10.1183/16000617.0103-2017</idno>
		<ptr target="https://doi.org/10.1183/16000617.0103-2017" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_MQnXWjC">European Respiratory Review</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">147</biblScope>
			<biblScope unit="page">170103</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">C. Viniol and C. F. Vogelmeier, &quot;Exacerbations of COPD,&quot; European Respiratory Review 27, no. 147 (2018): 170103, https:// doi. org/ 10. 1183/ 16000 617. 0103-2017.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_U2bMhQN">E-Monitoring of Asthma Therapy to Improve Compliance in Children (e-MATIC): A Randomised Controlled Trial</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Vasbinder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Goossens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Rutten-Van Mölken</surname></persName>
		</author>
		<idno type="DOI">10.1183/13993003.01698-2015</idno>
		<ptr target="https://doi.org/10.1183/13993003.01698-2015" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5XecV8h">European Respiratory Journal</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="758" to="767" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">E. C. Vasbinder, L. M. Goossens, M. P. Rutten-van Mölken, et al., &quot;E- Monitoring of Asthma Therapy to Improve Compliance in Children (e- MATIC): A Randomised Controlled Trial,&quot; European Respiratory Journal 48, no. 3 (2016): 758-767, https:// doi. org/ 10. 1183/ 13993 003. 01698 -2015.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<idno type="DOI">10.1093/ww/9780199540884.013.u164854</idno>
		<ptr target="https://www.who.int/publications/i/item/9789241550505" />
		<title level="m" xml:id="_4WuN8zh">WHO Guideline: Recommendations on Digital Interventions for Health System Strengthening</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2019-06-06">2019. 2019 Jun 6. Dec 16, 2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">WHO Guideline: Recommendations on Digital Interventions for Health System Strengthening (Geneva: World Health Organization, 2019). 2019 Jun 6 [cited Dec 16, 2023], https:// www. who. int/ publi catio ns/i/ item/ 97892 41550505.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_fcekkDr">Telehealth Interventions: Remote Monitoring and Consultations for People With Chronic Obstructive Pulmonary Disease (COPD)</title>
		<author>
			<persName><forename type="first">S</forename><surname>Janjua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J D</forename><surname>Threapleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Prigmore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Disler</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd013196.pub2</idno>
		<ptr target="https://doi.org/10.1002/14651858.CD013196.pub2" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_PTj6vuD">Cochrane Database of Systematic Reviews</title>
		<imprint>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">13196</biblScope>
			<date type="published" when="2021">2021. 2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S. Janjua, D. Carter, C. J. D. Threapleton, S. Prigmore, and R. T. Dis- ler, &quot;Telehealth Interventions: Remote Monitoring and Consultations for People With Chronic Obstructive Pulmonary Disease (COPD),&quot; Co- chrane Database of Systematic Reviews 2021, no. 7 (2021): CD013196, https:// doi. org/ 10. 1002/ 14651 858. CD013 196. pub2.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_AEhJD8u">Recent Insights in the Role of Biomarkers in Severe Asthma Management</title>
		<author>
			<persName><forename type="first">E</forename><surname>Fouka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Domvri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gkakou</surname></persName>
		</author>
		<idno type="DOI">10.3389/fmed.2022.992565</idno>
		<ptr target="https://doi.org/10.3389/fmed.2022.992565" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_nzVH2cX">Frontiers in Medicine</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">992565</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">E. Fouka, K. Domvri, F. Gkakou, et al., &quot;Recent Insights in the Role of Biomarkers in Severe Asthma Management,&quot; Frontiers in Medicine 9 (2022): 992565, https:// doi. org/ 10. 3389/ fmed. 2022. 992565.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_rGDxpWu">Biomarkers in Severe Asthma: Identifying the Treatable Trait</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gvalani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Athavale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gupta</surname></persName>
		</author>
		<idno type="DOI">10.4103/lungindia.lungindia_271_22</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_S3zK4Fg">Lung India</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="59" to="67" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Gvalani, A. Athavale, and D. Gupta, &quot;Biomarkers in Severe Asthma: Identifying the Treatable Trait,&quot; Lung India 40, no. 1 (2023): 59-67.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_cGBvtV6">Patient-Centered Digital Biomarkers for Allergic Respiratorydiseases and Asthma: The ARIA-EAACI Approach-ARIA-EAACI Task Force Report</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Shamji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Anto</surname></persName>
		</author>
		<idno type="DOI">10.1111/all.15740</idno>
		<ptr target="https://doi.org/10.1111/all.15740" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_FS5PNdA">Allergy-European Journal of Allergy and Clinical Immunology</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1758" to="1776" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. Bousquet, M. H. Shamji, J. M. Anto, et al., &quot;Patient-Centered Digital Biomarkers for Allergic Respiratorydiseases and Asthma: The ARIA-EAACI Approach-ARIA-EAACI Task Force Report,&quot; Al- lergy-European Journal of Allergy and Clinical Immunology 78, no. 7 (2023): 1758-1776, https:// doi. org/ 10. 1111/ all. 15740 .</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_wWr2wwe">Cost-Utility Analysis of a Telehealth Programme for Patients With Severe Chronic Obstructive Pulmonary Disease Treated With Long-Term Oxygen Therapy</title>
		<author>
			<persName><forename type="first">F</forename><surname>Jódar-Sánchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ortega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Parra</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x14544421</idno>
		<ptr target="https://doi.org/10.1177/1357633X14544421" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_32PCxmW">Journal of Telemedicine and Telecare</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="307" to="316" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">F. Jódar-Sánchez, F. Ortega, C. Parra, et al., &quot;Cost-Utility Analysis of a Telehealth Programme for Patients With Severe Chronic Obstructive Pulmonary Disease Treated With Long-Term Oxygen Therapy,&quot; Journal of Telemedicine and Telecare 20, no. 6 (2014): 307-316, https:// doi. org/ 10. 1177/ 13576 33X14 544421.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_HzuB82r">A Multicentre, Randomized Controlled Trial of Telehealth for the Management of COPD</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Soriano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>García-Río</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vázquez-Espinosa</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.rmed.2018.10.008</idno>
		<ptr target="https://doi.org/10.1016/j.rmed.2018.10.008" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_dWzGbaP">Respiratory Medicine</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="74" to="81" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. B. Soriano, F. García-Río, E. Vázquez-Espinosa, et al., &quot;A Multi- centre, Randomized Controlled Trial of Telehealth for the Management of COPD,&quot; Respiratory Medicine 144 (2018): 74-81, https:// doi. org/ 10. 1016/j. rmed. 2018. 10. 008.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_GPxYCEs">A Randomised Clinical Trial of the Effectiveness of Home-Based Health Care With Telemonitoring in Patients With COPD</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Mcdowell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcclean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fitzgibbon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tate</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x14566575</idno>
		<ptr target="https://doi.org/10.1177/1357633X14566575" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_vgGjN2V">Journal of Telemedicine and Telecare</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="80" to="87" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. E. McDowell, S. McClean, F. FitzGibbon, and S. Tate, &quot;A Randomised Clinical Trial of the Effectiveness of Home-Based Health Care With Tele- monitoring in Patients With COPD,&quot; Journal of Telemedicine and Telecare 21, no. 2 (2015): 80-87, https:// doi. org/ 10. 1177/ 13576 33X14 566575.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_7DgRRy4">Comparing the Costs of Home Telemonitoring and Usual Care of Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">G</forename><surname>Paré</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Poba-Nzaou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sicotte</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.eurtel.2013.05.001</idno>
		<ptr target="https://doi.org/10.1016/j.eurtel.2013.05.001" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_fB9KE7q">European Research in Telemedicine</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="35" to="47" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">G. Paré, P. Poba-Nzaou, C. Sicotte, et al., &quot;Comparing the Costs of Home Telemonitoring and Usual Care of Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial,&quot; European Research in Telemedicine 2, no. 2 (2013): 35-47, https:// doi. org/ 10. 1016/j. eurtel. 2013. 05. 001.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_Nqr44F5">Cost Effectiveness of Telehealth for Patients With Long Term Conditions (Whole Systems Demonstrator Telehealth Questionnaire Study): Nested Economic Evaluation in a Pragmatic, Cluster Randomised Controlled Trial</title>
		<author>
			<persName><forename type="first">C</forename><surname>Henderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Knapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Fernández</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.f1035</idno>
		<ptr target="https://doi.org/10.1136/bmj.f1035" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_XNbtyub">BMJ</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="page">1035</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">C. Henderson, M. Knapp, J. L. Fernández, et al., &quot;Cost Effectiveness of Telehealth for Patients With Long Term Conditions (Whole Systems Demonstrator Telehealth Questionnaire Study): Nested Economic Eval- uation in a Pragmatic, Cluster Randomised Controlled Trial,&quot; BMJ 346, no. 7902 (2013): f1035, https:// doi. org/ 10. 1136/ bmj. f1035 .</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_xy88c3X">Cost-Effectiveness of Telehealthcare to Patients With Chronic Obstructive Pulmonary Disease: Results From the Danish TeleCare North&apos; Cluster-Randomised Trial</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Udsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Lilholt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Hejlesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ehlers</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2016-014616</idno>
		<ptr target="https://doi.org/10.1136/bmjopen-2016-014616" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_JGw5Ak8">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">14616</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">F. W. Udsen, P. H. Lilholt, O. Hejlesen, and L. Ehlers, &quot;Cost- Effectiveness of Telehealthcare to Patients With Chronic Obstructive Pulmonary Disease: Results From the Danish TeleCare North&apos; Cluster- Randomised Trial,&quot; BMJ Open 7, no. 5 (2017): e014616, https:// doi. org/ 10. 1136/ bmjop en-2016-014616.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_5apTEpE">Cost-Utility Analysis of a Telerehabilitation Program: A Case Study of COPD Patients</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K E</forename><surname>Haesum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Soerensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dinesen</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2011.0250</idno>
		<ptr target="https://doi.org/10.1089/tmj.2011.0250" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_H2S7wsK">Telemedicine and e-Health</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="688" to="692" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">L. K. E. Haesum, N. Soerensen, B. Dinesen, et al., &quot;Cost-Utility Analysis of a Telerehabilitation Program: A Case Study of COPD Pa- tients,&quot; Telemedicine and e-Health 18, no. 9 (2012): 688-692, https:// doi. org/ 10. 1089/ tmj. 2011. 0250.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_PMD7cau">Follow-Up With Telemedicine in Early Discharge for COPD Exacerbations: Randomized Clinical Trial (TELEMEDCOPD-Trial)</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Mínguez</forename><surname>Clemente</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pascual-Carrasco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Mata</forename><surname>Hernández</surname></persName>
		</author>
		<idno type="DOI">10.1080/15412555.2020.1857717</idno>
		<ptr target="https://doi.org/10.1080/15412555.2020.1857717" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_bKnwbBF">COPD</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="62" to="69" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">P. Mínguez Clemente, M. Pascual-Carrasco, C. Mata Hernández, et al., &quot;Follow-Up With Telemedicine in Early Discharge for COPD Exac- erbations: Randomized Clinical Trial (TELEMEDCOPD-Trial),&quot; COPD 18, no. 1 (2021): 62-69, https:// doi. org/ 10. 1080/ 15412 555. 2020. 1857717.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_5yPBdB9">Home Initiation of Chronic Non-Invasive Ventilation in COPD Patients With Chronic Hypercapnic Respiratory Failure: A Randomised Controlled Trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Duiverman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Vonk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bladder</surname></persName>
		</author>
		<idno type="DOI">10.1136/thoraxjnl-2019-213303</idno>
		<ptr target="https://doi.org/10.1136/thoraxjnl-2019-213303" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_25rBDWT">Thorax</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="244" to="252" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. L. Duiverman, J. M. Vonk, G. Bladder, et al., &quot;Home Initiation of Chronic Non-Invasive Ventilation in COPD Patients With Chronic Hy- percapnic Respiratory Failure: A Randomised Controlled Trial,&quot; Thorax 75, no. 3 (2020): 244-252, https:// doi. org/ 10. 1136/ thora xjnl-2019-213303.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_D7SsvXr">Impact of a Hospital-Based Home-Care Program on the Management of COPD Patients Receiving Long-Term Oxygen Therapy</title>
		<author>
			<persName><forename type="first">E</forename><surname>Farrero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Escarrabill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Prats</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maderal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Manresa</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.119.2.364</idno>
		<ptr target="https://doi.org/10.1378/chest.119.2.364" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_uSapTZe">Chest</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="364" to="369" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">E. Farrero, J. Escarrabill, E. Prats, M. Maderal, and F. Manresa, &quot;Im- pact of a Hospital-Based Home-Care Program on the Management of COPD Patients Receiving Long-Term Oxygen Therapy,&quot; Chest 119, no. 2 (2001): 364-369, https:// doi. org/ 10. 1378/ chest. 119.2. 364.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_p9cQdCt">Tele-Assistance in Chronic Respiratory Failure Patients: A Randomised Clinical Trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Vitacca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bianchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Guerra</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.00005608</idno>
		<ptr target="https://doi.org/10.1183/09031936.00005608" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_rJu7x75">European Respiratory Journal</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="411" to="418" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. Vitacca, L. Bianchi, A. Guerra, et al., &quot;Tele-Assistance in Chronic Respiratory Failure Patients: A Randomised Clinical Trial,&quot; European Respiratory Journal 33, no. 2 (2009): 411-418, https:// doi. org/ 10. 1183/ 09031 936. 00005608.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_xAQbbW5">Telecare for Diabetes, CHF or COPD: Effect on Quality of Life, Hospital Use and Costs. A Randomised Controlled Trial and Qualitative Evaluation</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Kenealy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J G</forename><surname>Parsons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P B</forename><surname>Rouse</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0116188</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0116188" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_wKJZyCt">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">116188</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">T. W. Kenealy, M. J. G. Parsons, A. P. B. Rouse, et al., &quot;Telecare for Di- abetes, CHF or COPD: Effect on Quality of Life, Hospital Use and Costs. A Randomised Controlled Trial and Qualitative Evaluation,&quot; PLoS One 10, no. 3 (2015): e0116188, https:// doi. org/ 10. 1371/ journ al. pone. 0116188.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_VkcDK8F">Telehealth Remote Monitoring for Community-Dwelling Older Adults With Chronic Obstructive Pulmonary Disease</title>
		<author>
			<persName><forename type="first">K</forename><surname>De San Miguel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lewin</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2012.0244</idno>
		<ptr target="https://doi.org/10.1089/tmj.2012.0244" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_zYYJcnU">Telemedicine and e-Health</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="652" to="657" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">K. De San Miguel, J. Smith, and G. Lewin, &quot;Telehealth Remote Mon- itoring for Community-Dwelling Older Adults With Chronic Obstruc- tive Pulmonary Disease,&quot; Telemedicine and e-Health 19, no. 9 (2013): 652-657, https:// doi. org/ 10. 1089/ tmj. 2012. 0244.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_qNBhw7E">Telemonitoring for Chronic Obstructive Pulmonary Disease: A Cost and Cost-Utility Analysis of a Randomised Controlled Trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Stoddart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Der Pol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pinnock</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x14566574</idno>
		<ptr target="https://doi.org/10.1177/1357633X14566574" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_8pfN9gz">Journal of Telemedicine and Telecare</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="108" to="118" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Stoddart, M. van der Pol, H. Pinnock, et al., &quot;Telemonitoring for Chronic Obstructive Pulmonary Disease: A Cost and Cost-Utility Analy- sis of a Randomised Controlled Trial,&quot; Journal of Telemedicine and Tele- care 21, no. 2 (2015): 108-118, https:// doi. org/ 10. 1177/ 13576 33X14 566574.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_D8WE7BP">Telemonitoring in Chronic Obstructive Pulmonary Disease (Chromed) a Randomized Clinical Trial</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Pompilio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zanaboni</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201712-2404oc</idno>
		<ptr target="https://doi.org/10.1164/rccm.201712-2404OC" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_meCgCmk">American Journal of Respiratory and Critical Care Medicine</title>
		<imprint>
			<biblScope unit="volume">198</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="620" to="628" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">P. P. Walker, P. P. Pompilio, P. Zanaboni, et al., &quot;Telemonitoring in Chronic Obstructive Pulmonary Disease (Chromed) a Randomized Clinical Trial,&quot; American Journal of Respiratory and Critical Care Med- icine 198, no. 5 (2018): 620-628, https:// doi. org/ 10. 1164/ rccm. 20171 2-2404OC.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_hQYyPMu">Using Preventive Home Monitoring to Reduce Hospital Admission Rates and Reduce Costs: A Case Study of Telehealth Among Chronic Obstructive Pulmonary Disease Patients</title>
		<author>
			<persName><forename type="first">B</forename><surname>Dinesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Haesum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Soerensen</surname></persName>
		</author>
		<idno type="DOI">10.1258/jtt.2012.110704</idno>
		<ptr target="https://doi.org/10.1258/jtt.2012.110704" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_tUdKwCb">Journal of Telemedicine and Telecare</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="221" to="225" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">B. Dinesen, L. K. Haesum, N. Soerensen, et al., &quot;Using Preventive Home Monitoring to Reduce Hospital Admission Rates and Reduce Costs: A Case Study of Telehealth Among Chronic Obstructive Pulmo- nary Disease Patients,&quot; Journal of Telemedicine and Telecare 18, no. 4 (2012): 221-225, https:// doi. org/ 10. 1258/ jtt. 2012. 110704.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_cyPZJxT">A Pilot Randomised Controlled Trial of a Telehealth Intervention in Patients With Chronic Obstructive Pulmonary Disease: Challenges of Clinician-Led Data Collection</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Bentley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Mountain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1186/1745-6215-15-313</idno>
		<ptr target="https://doi.org/10.1186/1745-6215-15-313" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_2bJTh7d">Trials</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">313</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">C. L. Bentley, G. A. Mountain, J. Thompson, et al., &quot;A Pilot Ran- domised Controlled Trial of a Telehealth Intervention in Patients With Chronic Obstructive Pulmonary Disease: Challenges of Clinician-Led Data Collection,&quot; Trials 15, no. 1 (2014): 313, https:// doi. org/ 10. 1186/ 1745-6215-15-313.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_c92GnnG">A Randomised 2 × 2 Trial of Community Versus Hospital Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease Followed by Telephone or Conventional Follow-Up</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Waterhouse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Walters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Oluboyede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Lawson</surname></persName>
		</author>
		<idno type="DOI">10.3310/hta14060</idno>
		<ptr target="https://doi.org/10.3310/hta14060" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BeGvQkp">Health Technology Assessment (Winchester)</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1" to="164" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. C. Waterhouse, S. J. Walters, Y. Oluboyede, and R. A. Lawson, &quot;A Randomised 2 × 2 Trial of Community Versus Hospital Pulmonary Re- habilitation for Chronic Obstructive Pulmonary Disease Followed by Telephone or Conventional Follow-Up,&quot; Health Technology Assessment (Winchester) 14, no. 6 (2010): 1-164, https:// doi. org/ 10. 3310/ hta14060.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_JYVfWXN">Cost-Effectiveness of a Telemonitoring Program (telEPOC Program) in Frequently Admitted Chronic Obstructive Pulmonary Disease Patients</title>
		<author>
			<persName><forename type="first">C</forename><surname>Esteban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Antón</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moraza</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x211037207</idno>
		<ptr target="https://doi.org/10.1177/1357633X211037207" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ScduS5c">Journal of Telemedicine and Telecare</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="156" to="164" />
			<date type="published" when="2024">2024</date>
		</imprint>
	</monogr>
	<note type="raw_reference">C. Esteban, A. Antón, J. Moraza, et al., &quot;Cost-Effectiveness of a Telemonitoring Program (telEPOC Program) in Frequently Admitted Chronic Obstructive Pulmonary Disease Patients,&quot; Journal of Telemed- icine and Telecare 30, no. 1 (2024): 156-164, https:// doi. org/ 10. 1177/ 13576 33X21 1037207.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_gY9rUwN">Proactive Integrated Care Improves Quality of Life in Patients With COPD</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Koff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Cashman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Voelkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Vandivier</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.00063108</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BUwRA5S">European Respiratory Journal</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1031" to="1038" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">P. B. Koff, R. H. Jones, J. M. Cashman, N. F. Voelkel, and R. W. Van- divier, &quot;Proactive Integrated Care Improves Quality of Life in Patients With COPD,&quot; European Respiratory Journal 33, no. 5 (2009): 1031-1038.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_M2aSqXM">A Small-Scale Randomised Controlled Trial of Home Telemonitoring in Patients With Severe Chronic Obstructive Pulmonary Disease</title>
		<author>
			<persName><forename type="first">T</forename><surname>Shany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hession</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pryce</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x16659410</idno>
		<ptr target="https://doi.org/10.1177/1357633X16659410" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_d5AJswn">Journal of Telemedicine and Telecare</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="650" to="656" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">T. Shany, M. Hession, D. Pryce, et al., &quot;A Small-Scale Randomised Controlled Trial of Home Telemonitoring in Patients With Severe Chronic Obstructive Pulmonary Disease,&quot; Journal of Telemedicine and Telecare 23, no. 7 (2017): 650-656, https:// doi. org/ 10. 1177/ 13576 33X16 659410.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_4v4h9te">A Randomized Controlled Trial of an Interactive Voice Response Telephone System and Specialist Nurse Support for Childhood Asthma Management</title>
		<author>
			<persName><forename type="first">C</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Scuffham</surname></persName>
		</author>
		<idno type="DOI">10.3109/02770903.2010.493966</idno>
		<ptr target="https://doi.org/10.3109/02770903.2010.493966" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BBqPnz9">Journal of Asthma</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="768" to="773" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">C. Xu, M. Jackson, P. A. Scuffham, et al., &quot;A Randomized Controlled Trial of an Interactive Voice Response Telephone System and Specialist Nurse Support for Childhood Asthma Management,&quot; Journal of Asthma 47, no. 7 (2010): 768-773, https:// doi. org/ 10. 3109/ 02770 903. 2010. 493966.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_GhYAASy">Clinical and Economic Impact of Telemedicine in the Management of Pediatric Asthma in Jordan: A Pharmacist-Led Intervention</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B M</forename><surname>Shdaifat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Khasawneh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Alefan</surname></persName>
		</author>
		<idno type="DOI">10.1080/02770903.2021.1924774</idno>
		<ptr target="https://doi.org/10.1080/02770903.2021.1924774" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_2dKuk8n">Journal of Asthma</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1452" to="1462" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. B. M. Shdaifat, R. A. Khasawneh, and Q. Alefan, &quot;Clinical and Eco- nomic Impact of Telemedicine in the Management of Pediatric Asthma in Jordan: A Pharmacist-Led Intervention,&quot; Journal of Asthma 59, no. 7 (2022): 1452-1462, https:// doi. org/ 10. 1080/ 02770 903. 2021. 1924774.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_mhFEFQA">Cost-Effectiveness of a Nurse-Led Telemonitoring Intervention Based on Peak Expiratory Flow Measurements in Asthmatics: Results of a Randomised Controlled Trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C M</forename><surname>Willems</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Joore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J E</forename><surname>Hendriks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F M</forename><surname>Wouters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Severens</surname></persName>
		</author>
		<idno type="DOI">10.1186/1478-7547-5-10</idno>
		<ptr target="https://doi.org/10.1186/1478-7547-5-10" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_tzWvfVC">Cost Effectiveness and Resource Allocation</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">10</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">D. C. M. Willems, M. A. Joore, J. J. E. Hendriks, E. F. M. Wouters, and J. L. Severens, &quot;Cost-Effectiveness of a Nurse-Led Telemonitoring Inter- vention Based on Peak Expiratory Flow Measurements in Asthmatics: Results of a Randomised Controlled Trial,&quot; Cost Effectiveness and Re- source Allocation 5 (2007): 10, https:// doi. org/ 10. 1186/ 1478-7547-5-10.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_qFFpkUV">Cost-Effectiveness of Internet-Based Self-Management Compared With Usual Care in Asthma</title>
		<author>
			<persName><forename type="first">V</forename><surname>Van Der Meer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Van Den Hout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Bakker</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0027108</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0027108" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_CAnC4hJ">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">27108</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">V. van der Meer, W. B. van den Hout, M. J. Bakker, et al., &quot;Cost- Effectiveness of Internet-Based Self-Management Compared With Usual Care in Asthma,&quot; PLoS One 6, no. 11 (2011): e27108, https:// doi. org/ 10. 1371/ journ al. pone. 0027108.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_CpRvDMr">Cost-Effectiveness of Telephone or Surgery Asthma Reviews: Economic Analysis of a Randomised Controlled Trial</title>
		<author>
			<persName><forename type="first">H</forename><surname>Pinnock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mckenzie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sheikh</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pcrj.2004.10.002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kt33Mjn">British Journal of General Practice</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">511</biblScope>
			<biblScope unit="page" from="119" to="124" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">H. Pinnock, L. McKenzie, D. Price, and A. Sheikh, &quot;Cost- Effectiveness of Telephone or Surgery Asthma Reviews: Economic Analysis of a Randomised Controlled Trial,&quot; British Journal of General Practice 55, no. 511 (2005): 119-124.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_Ax2ekwY">Improving Asthma Control Through Telemedicine: A Study of Short-Message Service</title>
		<author>
			<persName><forename type="first">V</forename><surname>Ostojic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cvoriscec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Ostojic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Reznikoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stipic-Markovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tudjman</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2005.11.28</idno>
		<ptr target="https://doi.org/10.1089/tmj.2005.11.28" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_cbBHjHx">Telemedicine and e-Health</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="28" to="35" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">V. Ostojic, B. Cvoriscec, S. B. Ostojic, D. Reznikoff, A. Stipic- Markovic, and Z. Tudjman, &quot;Improving Asthma Control Through Telemedicine: A Study of Short-Message Service,&quot; Telemedicine and e- Health 11 (2005): 28-35, https:// doi. org/ 10. 1089/ tmj. 2005. 11. 28.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_6rNAyVx">Can Digital Communication Technology Reduce Health System Personnel Time? An Evaluation of Personnel Requirements and Costs in a Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Ritzwoller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Raebel</surname></persName>
		</author>
		<idno type="DOI">10.1093/tbm/ibaa130</idno>
		<ptr target="https://doi.org/10.1093/tbm/ibaa130" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_E37ac4s">Translational Behavioral Medicine</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="863" to="869" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">N. M. Wagner, D. P. Ritzwoller, M. A. Raebel, et al., &quot;Can Digital Communication Technology Reduce Health System Personnel Time? An Evaluation of Personnel Requirements and Costs in a Randomized Controlled Trial,&quot; Translational Behavioral Medicine 11, no. 3 (2021): 863-869, https:// doi. org/ 10. 1093/ tbm/ ibaa130.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_tduEWNZ">Online Asthma Management for Children Is Cost-Effective</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Van Den Wijngaart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kievit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roukema</surname></persName>
		</author>
		<idno type="DOI">10.1183/13993003.01413-2017</idno>
		<ptr target="https://doi.org/10.1183/13993003.01413-2017" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5UGjAG3">European Respiratory Journal</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page">1701413</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">L. S. Van Den Wijngaart, W. Kievit, J. Roukema, et al., &quot;Online Asthma Management for Children Is Cost-Effective,&quot; European Respi- ratory Journal 50 (2017): 1701413, https:// doi. org/ 10. 1183/ 13993 003. 01413 -2017.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_Tp547jc">A Randomised Controlled Study of the Effectiveness of Breathing Retraining Exercises Taught by a Physiotherapist Either by Instructional DVD or in Face-to-Face Sessions in the Management of Asthma in Adults</title>
		<author>
			<persName><forename type="first">M</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bruton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Little</surname></persName>
		</author>
		<idno type="DOI">10.3310/hta21530</idno>
		<ptr target="https://doi.org/10.3310/hta21530" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ewSvJpA">Health Technology Assessment (Winchester)</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">53</biblScope>
			<biblScope unit="page" from="1" to="161" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. Thomas, A. Bruton, P. Little, et al., &quot;A Randomised Controlled Study of the Effectiveness of Breathing Retraining Exercises Taught by a Physiotherapist Either by Instructional DVD or in Face-to-Face Ses- sions in the Management of Asthma in Adults,&quot; Health Technology As- sessment (Winchester) 21, no. 53 (2017): 1-161, https:// doi. org/ 10. 3310/ hta21530.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_skR48ZY">Randomized Trial of an Electronic Asthma Monitoring System Among New York City Children</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Jacobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lieblein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Fierman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eaACSaR">American Journal of Managed Care</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="809" to="814" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. S. Jacobson, A. Lieblein, A. H. Fierman, et al., &quot;Randomized Trial of an Electronic Asthma Monitoring System Among New York City Children,&quot; American Journal of Managed Care 15, no. 11 (2009): 809-814.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_ZXf4tkG">Targeted Routine Asthma Care in General Practice Using Telephone Triage</title>
		<author>
			<persName><forename type="first">K</forename><surname>Gruffydd-Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hollinghurst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Taylor</surname></persName>
		</author>
		<idno type="DOI">10.1038/pcrj.2003.28</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WtssX27">British Journal of General Practice</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">521</biblScope>
			<biblScope unit="page" from="918" to="923" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">K. Gruffydd-Jones, S. Hollinghurst, S. Ward, and G. Taylor, &quot;Tar- geted Routine Asthma Care in General Practice Using Telephone Tri- age,&quot; British Journal of General Practice 55, no. 521 (2005): 918-923.</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_QgWcHU2">A Randomized Controlled Trial of a Mobile Application-Assisted Nurse-Led Model Used to Improve Treatment Outcomes in Children With Asthma</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1111/jan.14143</idno>
		<ptr target="https://doi.org/10.1111/jan.14143" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_2w5VBuy">Journal of Advanced Nursing</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="3058" to="3067" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S. Lv, X. Ye, Z. Wang, et al., &quot;A Randomized Controlled Trial of a Mobile Application-Assisted Nurse-Led Model Used to Improve Treat- ment Outcomes in Children With Asthma,&quot; Journal of Advanced Nurs- ing 75, no. 11 (2019): 3058-3067, https:// doi. org/ 10. 1111/ jan. 14143 .</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_892jgJF">Effectiveness and Cost of Influenza Vaccine Reminders for Adults With Asthma or Chronic Obstructive Pulmonary Disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Shoup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Madrid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Koehler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_D3bwHNq">American Journal of Managed Care</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="405" to="e413" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. A. Shoup, C. Madrid, C. Koehler, et al., &quot;Effectiveness and Cost of Influenza Vaccine Reminders for Adults With Asthma or Chronic Obstructive Pulmonary Disease,&quot; American Journal of Managed Care 21, no. 7 (2015): e405-e413.</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_tWarGsq">The Cost-Effectiveness of Digital Health Interventions: A Systematic Review of the Literature</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gentili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Failla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Melnyk</surname></persName>
		</author>
		<idno type="DOI">10.3389/fpubh.2022.787135</idno>
		<ptr target="https://doi.org/10.3389/fpubh.2022.787135" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_8haYHH4">Frontiers in Public Health</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">787135</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Gentili, G. Failla, A. Melnyk, et al., &quot;The Cost-Effectiveness of Digital Health Interventions: A Systematic Review of the Literature,&quot; Frontiers in Public Health 10 (2022): 787135, https:// doi. org/ 10. 3389/ fpubh. 2022. 787135.</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_vUHyQPX">The Cost-Effectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic Review</title>
		<author>
			<persName><forename type="first">X</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Ming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>You</surname></persName>
		</author>
		<idno type="DOI">10.2196/13166</idno>
		<ptr target="https://doi.org/10.2196/13166" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ca8h8Rp">Journal of Medical Internet Research</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">13166</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">X. Jiang, W. K. Ming, and J. H. You, &quot;The Cost-Effectiveness of Dig- ital Health Interventions on the Management of Cardiovascular Dis- eases: Systematic Review,&quot; Journal of Medical Internet Research 21, no. 6 (2019): e13166, https:// doi. org/ 10. 2196/ 13166 .</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_vXGW8SY">Telemedicine in the OECD: An Umbrella Review of Clinical and Cost-Effectiveness, Patient Experience and Implementation</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Eze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mateus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cravo Oliveira</surname></persName>
		</author>
		<author>
			<persName><surname>Hashiguchi</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0237585</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0237585" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_c6hptMf">PLoS One</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">237585</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">N. D. Eze, C. Mateus, and T. Cravo Oliveira Hashiguchi, &quot;Tele- medicine in the OECD: An Umbrella Review of Clinical and Cost- Effectiveness, Patient Experience and Implementation,&quot; PLoS One 15, no. 8 (2020): e0237585, https:// doi. org/ 10. 1371/ journ al. pone. 0237585.</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_XvFFHSg">Determining if Telehealth Can Reduce Health System Costs: Scoping Review</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Snoswell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Comans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Caffery</surname></persName>
		</author>
		<idno type="DOI">10.2196/17298</idno>
		<ptr target="https://doi.org/10.2196/17298" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_rmKfkKw">Journal of Medical Internet Research</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">17298</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">C. L. Snoswell, M. L. Taylor, T. A. Comans, A. C. Smith, L. C. Gray, and L. J. Caffery, &quot;Determining if Telehealth Can Reduce Health Sys- tem Costs: Scoping Review,&quot; Journal of Medical Internet Research 22, no. 10 (2020): e17298, https:// doi. org/ 10. 2196/ 17298 .</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_t8ftzYe">Randomised Controlled Trials-The Gold Standard for Effectiveness Research: Study Design: Randomised Controlled Trials</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hariton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Locascio</surname></persName>
		</author>
		<idno type="DOI">10.1111/1471-0528.15199</idno>
		<ptr target="https://doi.org/10.1111/1471-0528.15199" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_NWBJ9tF">BJOG: An International Journal of Obstetrics and Gynaecology</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page">1716</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">E. Hariton and J. J. Locascio, &quot;Randomised Controlled Trials-The Gold Standard for Effectiveness Research: Study Design: Randomised Controlled Trials,&quot; BJOG: An International Journal of Obstetrics and Gynaecology 125, no. 13 (2018): 1716, https:// doi. org/ 10. 1111/ 1471-0528. 15199 .</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
